Press Release
July 14, 2021
Funding will advance Entos’ breakthrough AI and quantum mechanics-driven drug design platform. Opens new San Diego headquarters with state-of-the-art laboratory.
Nick brings 35 years of R&D experience across a broad spectrum of therapeutic areas and modalities
A statement from the Entos management team and Board of directors in memoriam of Naren Gupta
Nine Entos Team members among the #COVIDisAirborne team that is selected as Gordon Bell Finalists and featured in The New York Times
AI-Enabled multiscale computational microscopy of delta SARS-CoV-2 in a respiratory aerosol
NVIDIA Clara Discovery is powering the San Diego startup’s new machine learning approach for developing next-generation therapeutics
Unitary N-body tensor equivariant network with applications to quantum chemistry
Jack Taunton and Ken Brameld join Entos scientific advisory board
Envision: Interactive quantum chemistry free for academic and educational users
Tim brings unparalleled expertise in drug discovery, synthetic optimization, and data science
Polyolefin production enabled by quantum machine learning
Sarah brings a wealth of experience in pharma, synthesis, and discovery software
New partnership to create innovative platform for research and education
A machine learning potential for biological and organic chemistry with semi-empirical cost and DFT accuracy
Refine the OrbNet model to accurately predict energy, forces, and other response properties
Deep learning for quantum chemistry using symmetry-adapted atomic-orbital features
